GSA Capital Partners LLP Has $116,000 Holdings in agilon health, inc. (NYSE:AGL)

GSA Capital Partners LLP decreased its position in shares of agilon health, inc. (NYSE:AGL) by 65.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,463 shares of the company’s stock after selling 56,448 shares during the quarter. GSA Capital Partners LLP’s holdings in agilon health were worth $116,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of AGL. AQR Capital Management LLC raised its position in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares in the last quarter. Vanguard Group Inc. raised its position in agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after purchasing an additional 371,537 shares in the last quarter. Susquehanna Fundamental Investments LLC lifted its stake in agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of agilon health in the 2nd quarter valued at $1,849,000. Finally, Bank of New York Mellon Corp increased its stake in shares of agilon health by 18.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after purchasing an additional 174,883 shares during the last quarter.

agilon health Price Performance

Shares of AGL opened at $2.27 on Tuesday. The business has a 50-day moving average of $2.86 and a 200-day moving average of $4.72. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company has a market capitalization of $933.23 million, a price-to-earnings ratio of -2.41 and a beta of 0.60. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $13.76.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter in the previous year, the business posted ($0.06) EPS. As a group, equities research analysts anticipate that agilon health, inc. will post -0.47 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the company. Benchmark reaffirmed a “buy” rating and issued a $9.00 price objective on shares of agilon health in a research note on Thursday, August 8th. Evercore ISI reduced their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 8th. Royal Bank of Canada reiterated an “outperform” rating and set a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Barclays cut their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Finally, JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $6.05.

Insiders Place Their Bets

In related news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. The trade was a 42.03 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.20% of the company’s stock.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.